Prediction of hepatobiliary transport of drugs : Contribution of carrier-mediated transport in the detoxication of xenobiotics

药物肝胆转运的预测:载体介导的转运在外源物解毒中的贡献

基本信息

项目摘要

The biliary excretion plays an important role in the detoxication of xenobiotics. In the present study, we clarified the mechanism for the biliary excretion of organic anions including conjugative metabolites in normal SD rats and in Eisaihyper-bilirubinemic rats (EHBR) whose multispecific organic anion transporter on the bile canalicular membrane (cMOAT) is hereditarily defective. ATP-dependent uptake of glutathione conjugate of dinitrophenol and E3040 glucuronide into the isolated bile canalicular membrane vesicles (CMV) was observed only in SD rats, but not in EHBR.In contrast, E3040 sulfate uptake into CMV was not stimulated in the presence of ATP in CMV isolated from both SD and EHBR.These results suggest that glucuronide, but not sulfate, can be the substrate for cMOAT.Furthermore, we examined the molecular feature of cMOAT.We fixed our eyes upon the fact (1) that the substrate specificity of cMOAT resembles that of multidrug resistance associated protein (MRP), a primary active transporter located on the multidrug resistance tumor cells and (2) that a series of the primary active transporters possess conserved ATP-binding cassette (ABC) region, and prepared the degenerated PCR primer for the carboxy-terminal ABC of human MRP.A 421 bp fragment was amplified from the SD rat liver cDNA.Northern blot analysis of poly (A)+RNA from SD rat liver revealed the presence of 5 kb and 8.5kb mRNA species which hybridized to this fragment. In contrast, poly (A)+ RNA from EHBR did not hybridize to this fragment. These results suggest (1) that the impaired expression of this particular region might be related to the pathogenesis of hyperbilirubinemia in EHBR and that this region might encode part of cMOAT.
胆汁排泄在外源性物质的解毒过程中起重要作用。本研究阐明了正常SD大鼠和遗传性胆小管膜多特异性有机阴离子转运体(cMOAT)缺陷的高胆红素血症大鼠(EHBR)胆汁排泄有机阴离子(包括共轭代谢产物)的机制。仅在SD大鼠中观察到二硝基苯酚和E3040葡萄糖醛酸苷的谷胱甘肽结合物进入分离的胆小管膜囊泡(CMV)的ATP依赖性摄取,而在EHBR中未观察到。相反,在SD和EHBR分离的CMV中,存在ATP时,CMV对E3040硫酸盐的摄取不受刺激。这些结果表明,葡萄糖醛酸苷,而不是硫酸盐,可以成为cMOAT的底物。此外,我们研究了cMOAT的分子特征,发现cMOAT的底物特异性与多药耐药相关蛋白(MRP)相似,MRP是多药耐药肿瘤细胞上的主要活性转运蛋白; cMOAT的一系列主要活性转运蛋白具有保守的ATP结合盒(ABC)区,从SD大鼠肝cDNA中扩增出421 bp的片段,用北方印迹法对SD大鼠肝组织中的poly(A)+RNA进行杂交,结果显示与该片段杂交的mRNA分别为5 kb和8.5kb。相反,来自EHBR的poly(A)+ RNA不与该片段杂交。这些结果提示:(1)该区域的表达异常可能与EHBR高胆红素血症的发病机制有关,该区域可能编码cMOAT的一部分。

项目成果

期刊论文数量(40)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
K.Ito: "Expression of a putative ATP-binding cassette region,homologous to that in multidrug resistance associated protein(MRP),is hereditarily defective in Eisai hyperbilirubinemic rats(EHBR)." Int.Hepatol.Commun.,. in press. (1996)
K.Ito:“假定的 ATP 结合盒区域的表达与多药耐药相关蛋白 (MRP) 中的同源,在卫材高胆红素血症大鼠 (EHBR) 中存在遗传缺陷。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
O.Takenaka, t.Horie, H.Suzuki, K.Kobayashi and Y.Sugiyama: "Kinetic analysis of hepatobiliary transport for conjugative metabolites in the perfused liver of mutant rats (EHBR) with hereditary conjugative hyperbilirubinemia." Pharm.Res.12. 1746-1755 (1995)
O.Takenaka、t.Horie、H.Suzuki、K.Kobayashi 和 Y.Sugiyama:“遗传性结合性高胆红素血症的突变大鼠 (EHBR) 灌注肝脏中结合代谢物的肝胆转运动力学分析。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
山田 禎: "実験肝障害ラットにおける各種リガンドの肝移行能の変動" 薬理と治療(JPn.Pharmacol.Ther.). 22. S-71-S-77 (1994)
Yoshi Yamada:“实验性肝损伤大鼠中各种配体的肝脏转运能力的变化”药理学和治疗(JPn.Pharmacol.Ther.)22.S-71-S-77(1994)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
山崎雅代: "HMG-CoA還元酵素阻害剤Pravastatinの胆汁排泄機構:有機アニオン輸送系における多様性との関連" 薬理と治療. 23(Suppl.3). 59-66 (1995)
Masayo Yamazaki:“HMG-CoA还原酶抑制剂普伐他汀的胆汁排泄机制:与有机阴离子转运系统多样性的关系”药理学和治疗学23(Suppl.3)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
H.Sasabe, T.Terasaki, A.Tsuji and Y.Sugiyama: "Hepatobiliary excretion of Grepafloxacin, a novel quinolone antibiotic" Jpn.Pharmacol.Ther.(in press). (1996)
H.Sasabe、T.Terasaki、A.Tsuji 和 Y.Sugiyama:“格帕沙星(一种新型喹诺酮抗生素)的肝胆排泄”Jpn.Pharmacol.Ther.(出版中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUGIYAMA Yuichi其他文献

SUGIYAMA Yuichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUGIYAMA Yuichi', 18)}}的其他基金

Development of probe drugs for the evaluation of the functions of drug transporters in vivo in humans
开发用于评估人体内药物转运蛋白功能的探针药物
  • 批准号:
    20249008
  • 财政年份:
    2008
  • 资助金额:
    $ 10.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of the quantitative prediction method of pharmacokinetics with considering the function of metabolic enzymes and transporters
考虑代谢酶和转运蛋白功能的药代动力学定量预测方法的开发
  • 批准号:
    17209005
  • 财政年份:
    2005
  • 资助金额:
    $ 10.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
New strategy for the drug development of CNS acting drugs by regulating drug transport across the blood-brain barrier
通过调节药物跨血脑屏障转运开发中枢神经系统药物的新策略
  • 批准号:
    15390035
  • 财政年份:
    2003
  • 资助金额:
    $ 10.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of the system for prediction of drug-drug interactions in hepatobiliary transport process
肝胆转运过程中药物相互作用预测系统的开发
  • 批准号:
    13557219
  • 财政年份:
    2001
  • 资助金额:
    $ 10.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Drug design based on the substrate specificity of the efflux transporters expressed in the blood-brain barrier
基于血脑屏障中表达的外排转运蛋白的底物特异性的药物设计
  • 批准号:
    13470495
  • 财政年份:
    2001
  • 资助金额:
    $ 10.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of the vectorial transport of amino acid and drugs in epithelial cells.
上皮细胞中氨基酸和药物的载体运输分析。
  • 批准号:
    12144201
  • 财政年份:
    2000
  • 资助金额:
    $ 10.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Analysis of the factors governing the elimination route of therapeutic agents
控制治疗药物消除途径的因素分析
  • 批准号:
    11470509
  • 财政年份:
    1999
  • 资助金额:
    $ 10.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Role of hepatic transporters in the detoxification
肝脏转运蛋白在解毒中的作用
  • 批准号:
    10044243
  • 财政年份:
    1998
  • 资助金额:
    $ 10.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Development of recombinant proteins with an aim to increase their therapeutic activity by the regulation of intracellular sorting
开发重组蛋白,旨在通过调节细胞内分选来提高其治疗活性
  • 批准号:
    10557230
  • 财政年份:
    1998
  • 资助金额:
    $ 10.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of hepatic transporters in the detoxification
肝脏转运蛋白在解毒中的作用
  • 批准号:
    09044267
  • 财政年份:
    1997
  • 资助金额:
    $ 10.5万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了